Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6939310rdf:typepubmed:Citationlld:pubmed
pubmed-article:6939310lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:6939310lifeskim:mentionsumls-concept:C0037663lld:lifeskim
pubmed-article:6939310lifeskim:mentionsumls-concept:C0011570lld:lifeskim
pubmed-article:6939310lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:6939310lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:6939310lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:6939310lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:6939310pubmed:dateCreated1981-6-13lld:pubmed
pubmed-article:6939310pubmed:abstractTextWe interpreted our previous findings obtained with clonidine in depressive patients to indicate that in endogenous depressive patients--in contrast to neurotic depressive patients and controls--there is a reduced sensitivity of postsynaptic alpha-adrenergic receptors or of structures related to them. In the present study, after desipramine (DMI) (75 mg i.m.), endogenous depressives show a significantly reduced growth hormone (HGH) response as compared to neurotic depressive patients and to controls. The HGH response to DMI can be blocked by pretreatment with the alpha-blocker phentolamine (30 and 60 mg i.v.). Therefore we assume that in the DMI test, postsynaptic alpha-receptors are involved, thus giving further evidence for the importance of postsynaptic alpha-receptors in depression.lld:pubmed
pubmed-article:6939310pubmed:languageenglld:pubmed
pubmed-article:6939310pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6939310pubmed:citationSubsetIMlld:pubmed
pubmed-article:6939310pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6939310pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6939310pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6939310pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6939310pubmed:statusMEDLINElld:pubmed
pubmed-article:6939310pubmed:issn0065-1591lld:pubmed
pubmed-article:6939310pubmed:authorpubmed-author:MatussekNNlld:pubmed
pubmed-article:6939310pubmed:authorpubmed-author:LaakmannGGlld:pubmed
pubmed-article:6939310pubmed:issnTypePrintlld:pubmed
pubmed-article:6939310pubmed:volume290lld:pubmed
pubmed-article:6939310pubmed:ownerNLMlld:pubmed
pubmed-article:6939310pubmed:authorsCompleteYlld:pubmed
pubmed-article:6939310pubmed:pagination122-6lld:pubmed
pubmed-article:6939310pubmed:dateRevised2008-2-15lld:pubmed
pubmed-article:6939310pubmed:meshHeadingpubmed-meshheading:6939310-...lld:pubmed
pubmed-article:6939310pubmed:meshHeadingpubmed-meshheading:6939310-...lld:pubmed
pubmed-article:6939310pubmed:meshHeadingpubmed-meshheading:6939310-...lld:pubmed
pubmed-article:6939310pubmed:meshHeadingpubmed-meshheading:6939310-...lld:pubmed
pubmed-article:6939310pubmed:meshHeadingpubmed-meshheading:6939310-...lld:pubmed
pubmed-article:6939310pubmed:meshHeadingpubmed-meshheading:6939310-...lld:pubmed
pubmed-article:6939310pubmed:year1981lld:pubmed
pubmed-article:6939310pubmed:articleTitleGrowth hormone response in patients with depression.lld:pubmed
pubmed-article:6939310pubmed:publicationTypeJournal Articlelld:pubmed